ikcs 2020: session 5: multimodality therapy for metastatic rcc
Published 3 years ago • 44 plays • Length 2:09:09Download video MP4
Download video MP3
Similar videos
-
1:01:19
ikcs 2020: session 1: multimodality therapy for locally advanced rcc
-
1:33:22
ikcs 2020: session 3 immunotherapy and emerging therapies for rcc
-
50:08
ikcs 2020: non-clear cell rcc session
-
40:27
ikcs 2020 session 4: metabolism as a target for rcc
-
1:02
an expert looks to the future of metastatic kidney cancer treatment
-
29:47
aggressive systemic and multi-modal therapy to treat metastatic kidney cancer | uclamdchat
-
1:18
using radiotherapy to manage oligometastatic kidney cancer
-
10:55
ikcs 2020: phase 2 trial of lenvatinib at 2 starting doses everolimus in renal cell carcinoma (rcc)
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
1:37
immunotherapy combinations improve survival in advanced renal cell carcinoma
-
3:19
radvax: nivolumab / ipilimumab with sbrt for metastatic renal cell carcinoma
-
1:33
what treatment options do people with rare types of kidney cancer have?
-
3:18
new treatment option for advanced kidney cancer
-
4:16
metastatic rcc: decision trees for second-line therapy
-
0:23
kidney cancer trial (the radical study)
-
5:36
sequencing metastatic renal cell carcinoma treatments
-
20:11
cytoreductive surgery in the era of targeted therapy for kidney cancer